window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 26, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Rare Diseases

  • Cell & Gene Therapy,Clinical Trials,Movers & Shakers,Rare Diseases

    Ascidian boosts RNA therapy push with key hire and expert board for Stargardt trial

    Ascidian Therapeutics has appointed Murray Abramson as chief development officer. [...]

    June 30, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Drug Development,Rare Diseases

    Game-changing £7.5M prize launches to unlock AI drug targets for ALS

    20 global teams will receive early-stage funding and access to [...]

    June 25, 2025
  • Clinical Trials,Rare Diseases,Regulatory Affairs,Technology and platforms

    Can remote blood collection reinvent trial access? Tasso’s CTO explains how it can do just that

    Tasso is a healthcare technology company pioneering remote, patient-centric solutions [...]

    June 23, 2025
  • Partnerships & Funding,Rare Diseases

    Chiesi and Key2Brain extend global partnership to advance blood-brain barrier-crossing therapies for ultra-rare diseases

    Chiesi Group has signed a worldwide license agreement with Swedish [...]

    June 12, 2025
  • Clinical Trials,Drug Development,Rare Diseases

    Nicotinamide riboside shows promise in rare premature aging disease

    Researchers in Japan have reported encouraging findings from the first [...]

    June 9, 2025
Previous910

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Phesi data highlights 6.7% of global clinical trials affected by Middle East disruption
    Categories: Clinical Development, Clinical Trials, Data Management, Global health, Real world evidence
  • Genmab appoints Margarida Duarte as general manager for Europe and emerging markets
    Categories: Healthcare leadership, Mergers & Acquisitions, Movers & Shakers, Pharmaceuticals and therapeutics
  • Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America
    Categories: Healthcare leadership, Market Access & Commercialization, Movers & Shakers, Pharmaceuticals and therapeutics, Startups and innovations
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top